@article{ref1,
title="Notes from the field: emergency department visits and hospitalizations for buprenorphine ingestion by children - United States, 2010-2011",
journal="MMWR: Morbidity and mortality weekly report",
year="2013",
author="",
volume="62",
number="3",
pages="56-56",
abstract="Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.<p /> <p>Language: en</p>",
language="en",
issn="0149-2195",
doi="",
url="http://dx.doi.org/"
}